Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?

Similar Items

• Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study
  od: Mori, Hideki, i dr.
  Izdano: (2015)
• A Prospective Trial in Saudi Arabia Comparing the 14-day Standard Triple Therapy with the 10-day Sequential Therapy for Treatment of Helicobacter pylori Infection: A Further Confirmation of “Geographic Weight”
  od: Losurdo, Giuseppe, i dr.
  Izdano: (2016)
• Role of concomitant therapy for Helicobacter pylori eradication: A technical note
  od: Losurdo, Giuseppe, i dr.
  Izdano: (2016)
• Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
  od: Ierardi, Enzo, i dr.
  Izdano: (2017)
• Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?
  od: Giorgio, Floriana, i dr.
  Izdano: (2013)